SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ:QDEL), a leader in point-of-care rapid diagnostic tests, announced today that the company has not seen the typical seasonal spike in demand for its influenza tests. Although it is not possible for the company to predict the ultimate outcome of the domestic 2008/2009 influenza season, as of today, the influenza season appears to be marked by both a late start as well as weakness in overall flu incidence.
